Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAndrew A. House, Stefan Störk, Christopher R. deFilippi et al.|Kidney International|2019Cited by 435
Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanismEndin Nokik Stujanna, Kazutaka Aonuma|PLoS ONE|2017Cited by 100
The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillationSatoshi Ogawa, Teiichi Yamane, Kazutaka Aonuma et al.|Journal of Arrhythmia|2013Cited by 82
The Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Improves Hypoxia-Induced Pulmonary Hypertension in Mice Partly via Normalization of Reduced ETB Receptor ExpressionJunya Honda, Kazutaka Aonuma|Physiological Research|2018Cited by 19